原文出处:U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
(生物谷Bioon.com) 原文出处:U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia 版权声明 本网站所有注明“来源:生物谷”或“来源:bioon”的文字、图片和音视频资料,版权均属于...
2.American Cancer Society (ACS). COVID-19 Vaccines in People with Cancer. February 2, 2023. Available at https://www.cancer.org/treatment/coronavirus-covid-19-and-cancer/covid-19-vaccines-in-people-with-cancer.html. Accessed February ...
Improved Results of AML Treatment in Adults during a 12-Year Period. A Population-Based StudySchmidt, K.Gram-Hansen, P.Brincker, H.Christensen, B. E.Andersen, T. M.HAEMATOLOGY AND BLOOD TRANSFUSION
百时美施贵宝(BMS)今天宣布,美国FDA已批准该公司开发的Onureg(阿扎胞苷300 mg片剂,又名CC-486)上市,作为继续治疗(continued treatment)手段,治疗经强力诱导化疗后获得首次完全缓解(CR)或CR伴血细胞计数不完全缓解(CRi)的成人急性髓系白血病(AML)患者。这些患者获得首次完全缓解之后不能继续接受强力治愈性疗法。
9. Kurtin S. Interdisciplinary management of acute leukemia across the continuum of care. Sem Oncol Nursing. 2019;35:150953. doi:10.1016/j.soncn. 10. Leak Bryant A, Chan Y, Richardson J, et al. Understanding barriers to oral therapy adherenc...
[2]Lo-Coco F, Avvisati G, Vignetti M, et al.: Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood 116 (17): 3171-9, 2010. ...
During the treatment of 89 pediatric patients with Acute Myeloid Leukemia (AML) at the Hematology Department of Kunming Medical University’s Children’s Hospital from 2020 to 2023, three patients were identified to co-express the NUP98-NSD1, FLT3-ITD, a
2022 ELN recommendations for the diagnosis of AML in adults Add bookmark EHA 2024 top abstracts: What’s hot in AML? Add bookmark ISAL 2019 | The role of minimal residual disease guided treatment in acute myeloid leukemia Add bookmark ...
2022 ELN recommendations for the diagnosis of AML in adults Add bookmark ISAL 2019 | The role of minimal residual disease guided treatment in acute myeloid leukemia Add bookmark Recent advancements in the use of menin inhibitors for AML: Highlights from EHA 2024 ...